FDA
label_change
· 2025-03-21
FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
Summary
FDA approved a supplemental application for Aimovig (erenumab-aooe) submitted by Amgen. The approval updates the product labeling per the supplemental submissio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AIMOVIG (ERENUMAB-AOOE)